The use of OKT3 in the treatment of acute vascular rejection.
Schroeder
T J
TJ
Department of Pathology, University of Cincinnati Medical Center, Ohio 45267-0714.
Weiss
M A
MA
Smith
R D
RD
Stephens
G W
GW
Carey
M
M
First
M R
MR
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001808:Blood Vessels / Q000276:immunology*; D003404:Creatinine / Q000097:blood; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000379:methods*; D016853:Muromonab-CD3
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D003404:Creatinine